Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-K/A for the period ended Dec 31, 2013

Filed with the SEC on Apr 24, 2014 and accepted by EDGAR at Apr 24, 2014, 20:34 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2013-01-01 to 2013-12-31$1.2kus-gaap:SalesRevenueNet
Gross profit12 months2013-01-01 to 2013-12-31$1.2kus-gaap:GrossProfit
Operating income12 months2013-01-01 to 2013-12-31−$25.1kus-gaap:OperatingIncomeLoss
Net income12 months2013-01-01 to 2013-12-31−$30.6kus-gaap:NetIncomeLoss
Diluted EPS12 months2013-01-01 to 2013-12-31−$0.01us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2013-01-01 to 2013-12-31−$25.1kus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash and equivalentsAt period end2013-12-31$525us-gaap:Cash
Current assetsAt period end2013-12-31$525us-gaap:AssetsCurrent
Total assetsAt period end2013-12-31$525us-gaap:Assets
Current liabilitiesAt period end2013-12-31$30.8kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-12-31$30.8kus-gaap:Liabilities
Shareholders' equityAt period end2013-12-31−$30.3kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-14-024610. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.